Brain Scientific Updates Disposable EEG Headset Sales Plan, Supply Scale-Up, and IP Status

by NASDAQ Market News June 17, 2020

NASDAQ Market News
Click here to email author

Aclaris Therapeutics Supports Investigator-Initiated Clinical Trial of ATI-450 for Cytokine Release Syndrome in Hospitalized Patients with COVID-19

Affimed Announces Successful Completion of First Dose Cohort in First-in-Human Phase 1/2A Study of AFM24 for the Treatment of Advanced EGFR-Expressing Solid Tumors Including Colon, Lung and Other Cancers

Ads